Search
for
Sort by
Research 841–870 of 1000+
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Les hormones sexuelles et la peau : questionnaire à l'attention des vétérinaires praticiens. Mise à jour bibliographique et synthèse
- ALOPECIA AREATA IN INFANTS: IS IT UNCOMMON?
- Pharmacology of antiandrogens
- Melanocytes: The new Black
- Adverse effects of common medications on male fertility
- Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review
- Botulinum Toxin Off-Label Use in Dermatology: A Review
- Metabolic Syndrome Prevalence in Psoriasis
- The Potential Role of Minoxidil in the Hair Transplantation Setting
- Topical use of systemic drugs in dermatology: A comprehensive review
- Congenital adrenal hyperplasia
- Congenital atrichia and hypotrichosis
- Dermatology and Pregnancy
- STEROID HORMONES IN GERIATRICS
- Effects of High-dose Radioactive Iodine Therapy on Hormonal Profiles and Sperm Quality in Thyroidectomy Patients
- Periodontal Manifestations of Diseases/Conditions Related with Female Sex Steroid Hormones
- Primary cutaneous follicle center lymphoma presenting as frontal fibrosing alopecia
- The skin and obesity
- Immunoglobulin E and Serum Interleukin-13 and Bacteria in Patients with Alopecia Areata
- Analysis of androgen receptor expression and activity in the mouse brain
- Cancer risk in polycystic ovary syndrome patients: Common treatments and future perspectives
- Novel type 1 5a-reductase Inhibitors with Antiproliferative Potential on LNCaP cells
- Program and Abstract of 16th APALMS 2018
- Trichotillomania and Traction Alopecia
- Telogen effluvium and associated incidence of abnormal serum ferritin, zinc, 25-hydroxy vitamin D, and thyroid-stimulating hormone
- Safety and efficacy of tavaborole (AN2690), a novel boron-based molecule, in 3 phase II trials for the topical treatment of toenail onychomycosis
- Minimal systemic exposure of a new topical triazole antifungal, efinaconazole 10% solution, in patients with severe onychomycosis following 28-day treatment
- Non-Neoplastic Disorders of Hair
- Clinical Management in Psychodermatology